Survival and Prognostic Factors in Systemic Sclerosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis

Survival in Systemic Sclerosis–related Pulmonary Arterial Hypertension in the Modern Treatment Era

(2013) Reda E. Girgis et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Hemodynamics in Pulmonary Arterial Hypertension: Current and Future Perspectives

(2012) Rajan Saggar et al.   AMERICAN JOURNAL OF CARDIOLOGY

Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension

(2012) S. Günther et al.   ARTHRITIS AND RHEUMATISM

Survivor bias and risk assessment

(2012) Dave P. Miller et al.   EUROPEAN RESPIRATORY JOURNAL

Warfarin in Systemic Sclerosis-associated and Idiopathic Pulmonary Arterial Hypertension. A Bayesian Approach to Evaluating Treatment for Uncommon Disease

(2012) S. R. JOHNSON et al.   JOURNAL OF RHEUMATOLOGY

Development of prognostic tools in pulmonary arterial hypertension: Lessons from modern day registries

(2012) Mardi Gomberg-Maitland et al.   THROMBOSIS AND HAEMOSTASIS

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

(2011) J. Fransen et al.   ANNALS OF THE RHEUMATIC DISEASES

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

(2011) Jérôme Le Pavec et al.   ARTHRITIS AND RHEUMATISM

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival

(2011) Marc Humbert et al.   ARTHRITIS AND RHEUMATISM

Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease

(2011) David Launay et al.   CHEST

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

(2011) Raymond L. Benza et al.   CHEST

ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre

(2011) J. Hurdman et al.   EUROPEAN RESPIRATORY JOURNAL

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

(2010) Aránzazu Campo et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Systemic Sclerosis-associated Pulmonary Arterial Hypertension

(2010) Jérôme Le Pavec et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group

(2010) J. Avouac et al.   ANNALS OF THE RHEUMATIC DISEASES

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL

(2010) Lorinda Chung et al.   CHEST

Pulmonary Hypertension in COPD: Epidemiology, Significance, and Management

(2010) Omar A. Minai et al.   CHEST

Predicting Survival in Pulmonary Arterial Hypertension

(2010) Raymond L. Benza et al.   CIRCULATION

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

(2010) Marc Humbert et al.   CIRCULATION

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

(2010) M. Humbert et al.   EUROPEAN RESPIRATORY JOURNAL

Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult

(2010) R Hesselstrand et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease

(2009) Stephen C. Mathai et al.   ARTHRITIS AND RHEUMATISM

Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?

(2009) Eric Hachulla et al.   CHEST

Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension

(2009) S. C. Mathai et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome

(2009) V. Cottin et al.   EUROPEAN RESPIRATORY JOURNAL

Guidelines for the diagnosis and treatment of pulmonary hypertension

(2009) et al.   EUROPEAN RESPIRATORY JOURNAL

Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma

(2009) M. C. GARIN et al.   JOURNAL OF RHEUMATOLOGY

Lack of Specificity of the 6-Minute Walk Test as an Outcome Measure for Patients with Systemic Sclerosis

(2009) Y. SCHOINDRE et al.   JOURNAL OF RHEUMATOLOGY

Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol

(2009) D. B. BADESCH et al.   JOURNAL OF RHEUMATOLOGY

Updated Clinical Classification of Pulmonary Hypertension

(2009) Gérald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study

(2009) E. Hachulla et al.   RHEUMATOLOGY

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

(2009) D. Launay et al.   RHEUMATOLOGY

Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases

(2009) Emmanuel Weitzenblum et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era

(2008) Robin Condliffe et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pulmonary hypertension in COPD

(2008) A. Chaouat et al.   EUROPEAN RESPIRATORY JOURNAL